Syndax Pharmaceuticals Q2 2025 Earnings Preview

9 hours ago 1

Syndax Pharmaceuticals (NASDAQ:SNDX) is scheduled to announce Q2 earnings results on Monday, August 4th, after market close.
The consensus EPS Estimate is -$1.01 and the consensus Revenue Estimate is $26.64M.
Over the last 3 months, EPS estimates have seen 4

Recommended For You